Pfizer Announces Layoffs as COVID Vaccine Revenue Slumps

South Africa News News

Pfizer Announces Layoffs as COVID Vaccine Revenue Slumps
South Africa Latest News,South Africa Headlines
  • 📰 Newsweek
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 52%

The pharmaceutical giant has announced it will slash its headcount to save money through 2024, though it did not specify how many jobs will be lost.

Pfizer is slashing its headcount after announcing it was going to cut its full-year revenue forecast by 13 percent earlier this week amid slumping sales of its COVID-19 vaccine.On October 13, the American pharmaceutical and biotechnology corporation said it expected its revenue for 2023 to be between $58 billion and $61 billion, down from an initial forecast of between $67 billion and $70 billion.The company earned record revenue topping $100 billion last year.

Posts on social media say that Pfizer held a live stream with thousands of employees to announce the layoffs. Newsweek could not verify whether the claims are true, but contacted Pfizer's media team for comment by email on Friday.According to screenshots shared on Reddit and allegedly taken from a live stream with Pfizer executives, employees were critical of the company, with one asking if the leadership team 'will painfully readjust their salaries too.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Newsweek /  🏆 468. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ford announces more layoffs after Kentucky strikeFord announces more layoffs after Kentucky strikeFord on Wednesday said it will fire more workers in Michigan a week after thousands of workers walked off the job at the company's Louisville, Kentucky, plant.
Read more »

Pfizer Prices Covid Drug Paxlovid at $1,400 for a Five-Day CoursePfizer Prices Covid Drug Paxlovid at $1,400 for a Five-Day CourseDrugmaker is expected to offer steep discounts to ensure wide access
Read more »

Pfizer to price COVID treatment Paxlovid at $1,390 per coursePfizer to price COVID treatment Paxlovid at $1,390 per coursePfizer on Wednesday (PFE.N) said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to commercial sales after government stocks run out.
Read more »

Pfizer to price Covid drug Paxlovid at $1,390 per coursePfizer to price Covid drug Paxlovid at $1,390 per coursePaxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treatments slumps nationwide.
Read more »

Pfizer to price Covid drug Paxlovid at $1,390 per coursePfizer to price Covid drug Paxlovid at $1,390 per coursePaxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treatments slumps nationwide.
Read more »

Pfizer Will Charge $1,390 For 1 Course Of COVID Drug Paxlovid On Commercial MarketPfizer Will Charge $1,390 For 1 Course Of COVID Drug Paxlovid On Commercial MarketNick Visser is a senior reporter on HuffPost’s breaking news team, covering the environment, U.S. politics and world news. Originally based in New York, he now lives in Sydney.
Read more »



Render Time: 2025-02-26 16:07:58